Immune cell profiling and circulating tumour cell analysis can aid risk stratification and personalized decision-making in newly diagnosed multiple myeloma patients
What is multiple myeloma? Multiple myeloma (also called myeloma) is the over-proliferation of abnormal plasma cells (which normally make antibodies) in the bone marrow (Figs 1&2).












